We are pleased to share a compelling new interview with Professor Konstantinos Tsioufis and Professor Sofie Brouwers, offering expert insights into the evolving landscape of hypertension management and the growing role of Ultrasound Renal Denervation (uRDN).

Hypertension Guidelines: ESC vs. ESH – What’s Changing?

In this expert discussion, Professors Tsioufis and Brouwers compare the latest European Society of Cardiology (ESC) and European Society of Hypertension (ESH) guidelines, highlighting both their similarities and their unique approaches to treatment. They explore the real-world impact of these updates, including how patient preference, referral pathways, and clinical data are shaping the future of hypertension care.

Best Practice: Identifying the Right Patients for RDN

Renal denervation is gaining recognition as a powerful adjunctive treatment in hypertension – but selecting the right patient is critical. This interview emphasizes how current ESC and ESH guidelines, along with tools like the Recor Medical patient selection form, are supporting physicians in identifying the most appropriate candidates for the procedure.

Research & Publications: Are We Ready for Widespread RDN Adoption?

A recent nationwide analysis suggests that up to 35 million Americans could be eligible for renal denervation, underscoring the vast potential of this intervention. However, with approximately 30% of patients not responding to RDN, the interview raises important questions about large-scale implementation, risk management, and future research directions.

Measurement Matters: Why Blood Pressure Accuracy is Critical

An additional highlight is the importance of accurate blood pressure measurement. A recent clinical trial shows that arm positioning can lead to discrepancies of up to 6.5 mmHg, enough to cause misdiagnosis or unnecessary treatment. The experts underline the importance of standardizing measurement techniques in daily practice.

Read the full interview here and explore how updated guidelines, evidence-based tools, and ongoing research are transforming hypertension care.